Winfield Associates’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-87
| Closed | -$28K | – | 176 |
|
|
2017
Q4 | $28K | Sell |
87
-196
| -69% | -$63.1K | 0.01% | 254 |
|
|
2017
Q3 | $89K | Sell |
283
-92
| -25% | -$28.9K | 0.05% | 152 |
|
|
2017
Q2 | $102K | Sell |
375
-92
| -20% | -$25K | 0.06% | 148 |
|
|
2017
Q1 | $128K | Buy |
467
+67
| +17% | +$18.4K | 0.07% | 137 |
|
|
2016
Q4 | $113K | Sell |
400
-40
| -9% | -$11.3K | 0.07% | 139 |
|
|
2016
Q3 | $138K | Buy |
440
+40
| +10% | +$12.5K | 0.09% | 126 |
|
|
2016
Q2 | $97K | Sell |
400
-20
| -5% | -$4.85K | 0.06% | 140 |
|
|
2016
Q1 | $109K | Buy |
420
+20
| +5% | +$5.19K | 0.07% | 128 |
|
|
2015
Q4 | $123K | Hold |
400
| – | – | 0.08% | 125 |
|
|
2015
Q3 | $117K | Sell |
400
-100
| -20% | -$29.3K | 0.09% | 123 |
|
|
2015
Q2 | $202K | Buy |
500
+200
| +67% | +$80.8K | 0.14% | 109 |
|
|
2015
Q1 | $127K | Buy |
300
+200
| +200% | +$84.7K | 0.09% | 128 |
|
|
2014
Q4 | $34K | Hold |
100
| – | – | 0.03% | 178 |
|
|
2014
Q3 | $33K | Hold |
100
| – | – | 0.02% | 179 |
|
|
2014
Q2 | $31K | Sell |
100
-50
| -33% | -$15.5K | 0.02% | 190 |
|
|
2014
Q1 | $46K | Buy |
+150
| New | +$46K | 0.04% | 162 |
|